Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies

Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is characterized by a high mortality rate and poor prognosis. Current treatments for PDAC, are ineffective due to a prominent immunosuppressive PDAC tumor microenvironment (TME). Although B lymphocytes are highly inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Senturk, Zeynep Nur, Akdag, Isilay, Deniz, Bahar, Sayi-Yazgan, Ayca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076755/
https://www.ncbi.nlm.nih.gov/pubmed/37033931
http://dx.doi.org/10.3389/fimmu.2023.1152551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076755/
https://www.ncbi.nlm.nih.gov/pubmed/37033931
http://dx.doi.org/10.3389/fimmu.2023.1152551

Ejemplares similares